Herpes simplex virus glycoproteins gH/gL and gb Bind Toll-Like Receptor 2, and Soluble gH/gL Is sufficient to activate NF-κB

Journal of Virology

Volumn 86, Issue 12, 2012, Pages 6555-6562

  Leoni, Valerio ^a   Gianni, Tatiana ^a   Salvioli, Stefano ^a   Campadelli Fiume, Gabriella ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GB PROTEIN; GH PROTEIN; GL PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL ADHESION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INNATE IMMUNITY; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; VIRION; VIRUS CELL INTERACTION;

HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; NF-KAPPA B; PROTEIN BINDING; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; VIRAL ENVELOPE PROTEINS;

HERPESVIRIDAE; SIMPLEXVIRUS;

EID: 84864010826     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00295-12     Document Type: Article

References (61)

1. Arii J, et al. 2010. Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1. Nature 467:859-862.
2. Atanasiu D, Saw WT, Cohen GH, Eisenberg RJ. 2010. Cascade of events governing cell-cell fusion induced by herpes simplex virus glycoproteins gD, gH/gL, and gB. J. Virol. 84:12292-12299.
3. Atanasiu D, et al. 2007. Bimolecular complementation reveals that glycoproteins gB and gH/gL of herpes simplex virus interact with each other during cell fusion. Proc. Natl. Acad. Sci. U. S. A. 104:18718 -18723.
4. Avitabile E, Forghieri C, Campadelli-Fiume G. 2007. Complexes between herpes simplex virus glycoproteins gD, gB, and gH detected in cells by complementation of split enhanced green fluorescent protein. J. Virol. 81:11532-11537.
5. Avitabile E, Forghieri C, Campadelli-Fiume G. 2009. Cross talk among the glycoproteins involved in herpes simplex virus entry and fusion: the interaction between gB and gH/gL does not necessarily require gD. J. Virol. 83:10752-10760.
6. Avitabile E, Lombardi G, Campadelli-Fiume G. 2003. Herpes simplex virus glycoprotein K, but not its syncytial allele, inhibits cell-cell fusion mediated by the four fusogenic glycoproteins, gD, gB, gH, and gL. J. Virol. 77:6836-6844.
7. Bender FC, Whitbeck JC, Lou H, Cohen GH, Eisenberg RJ. 2005. Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry. J. Virol. 79:11588 -11597.
8. Boehme KW, Guerrero M, Compton T. 2006. Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J. Immunol. 177:7094 -7102.
9. Cai WH, Gu B, Person S. 1988. Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. J. Virol. 62:2596 -2604.
10. Campadelli-Fiume G, et al. 2007. The multipartite system that mediates entry of herpes simplex virus into the cell. Rev. Med. Virol. 17:313-326.
11. Campadelli-Fiume G, Menotti L, Avitabile E, Gianni T. 2012. Viral and cellular contributions to herpes simplex virus entry into the cell. Curr. Opin. Virol. 2:28 -36.
12. Connolly SA, Jackson JO, Jardetzky TS, Longnecker R. 2011. Fusing structure and function: a structural view of the herpesvirus entry machinery. Nat. Rev. Microbiol. 9:369 -381.
13. Cotter CR, et al. 2011. The virion host shutoff protein of herpes simplex virus 1 blocks the replication-independent activation of NF-kappaB in dendritic cells in the absence of type I interferon signaling. J. Virol. 85: 12662-12672.
14. D'Addario M, Ahmad A, Morgan A, Menezes J. 2000. Binding of the Epstein-Barr virus major envelope glycoprotein gp350 results in the upregulation of the TNF-alpha gene expression in monocytic cells via NF-kappaB involving PKC, PI3-K and tyrosine kinases. J. Mol. Biol. 298:765-778.
15. Daubeuf S, et al. 2009. HSV ICP0 recruits USP7 to modulate TLRmediated innate response. Blood 113:3264 -3275.
16. DE Oliveira DE, Ballon G, Cesarman E. 2010. NF-kappaB signaling modulation by EBV and KSHV. Trends Microbiol. 18:248 -257.
17. Ejercito PM, Kieff ED, Roizman B. 1968. Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. J. Gen. Virol. 2:357-364.
18. Forrester A, et al. 1992. Construction and properties of a mutant of herpes simplex virus type 1 with glycoproteinHcoding sequences deleted. J. Virol. 66:341-348.
19. Gianni T, Amasio M, Campadelli-Fiume G. 2009. Herpes simplex virus gD forms distinct complexes with fusion executors gB and gH/gL through the C-terminal profusion. J. Biol. Chem. 284:17370 -17382.
20. Gianni T, et al. 2010. Herpes simplex virus glycoproteins H/L bind to cells independently of {alpha}V{beta}3 integrin and inhibit virus entry, and their constitutive expression restricts infection. J. Virol. 84:4013- 4025.
21. Gregory D, Hargett D, Holmes D, Money E, Bachenheimer SL. 2004. Efficient replication by herpes simplex virus type 1 involves activation of the IkappaB kinase-IkappaB-p65 pathway. J. Virol. 78:13582-13590.
22. Guo Y, et al. 2011. Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity. J. Exp. Med. 208:2083-2098.
23. Hargett D, Rice S, Bachenheimer SL. 2006. Herpes simplex virus type 1 ICP27-dependent activation of NF-kappaB. J. Virol. 80:10565-10578.
24. Kawai T, Akira S. 2007. Signaling to NF-kappaB by Toll-like receptors. Trends Mol. Med. 13:460-469.
25. Kim JC, et al. 2008. HSV-1 ICP27 suppresses NF-kappaB activity by stabilizing IkappaBalpha. FEBS Lett. 582:2371-2376.
26. Kousoulas KG, Huo B, Pereira L. 1988. Antibody-resistant mutations in cross-reactive and type-specific epitopes of herpes simplex virus 1 glycoprotein B map in separate domains. Virology 166:423- 431.
27. Kurt-Jones EA, et al. 2005. The role of Toll-like receptors in herpes simplex infection in neonates. J. Infect. Dis. 191:746 -748.
28. Kurt-Jones EA, et al. 2004. Herpes simplex virus 1 interaction with Tolllike receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. U. S. A. 101:1315-1320.
29. Ligas MW, Johnson DC. 1988. A herpes simplex virus mutant in which glycoprotein D sequences are replaced by beta-galactosidase sequences binds to but is unable to penetrate into cells. J. Virol. 62:1486 -1494.
30. Liu X, Fitzgerald K, Kurt-Jones E, Finberg R, Knipe DM. 2008. Herpesvirus tegument protein activates NF-kappaB signaling through the TRAF6 adaptor protein. Proc. Natl. Acad. Sci. U. S. A. 105:11335-11339.
31. Lopez P, Jacob RJ, Roizman B. 2002. Overexpression of promyelocytic leukemia protein precludes the dispersal of ND10 structures and has no effect on accumulation of infectious herpes simplex virus 1 or its proteins. J. Virol. 76:9355-9367.
32. Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A. 2003. Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198:513-520.
33. MacLeod IJ, Minson T. 2010. Binding of herpes simplex virus type-1 virions leads to the induction of intracellular signalling in the absence of virus entry. PLoS One 5:e9560. doi:10.1371/journal.pone.0009560.
34. Medici MA, et al. 2003. Protection by herpes simplex virus glycoprotein D against Fas-mediated apoptosis: role of nuclear factor kappaB. J. Biol. Chem. 278:36059 -36067.
35. Melchjorsen J. 2012. Sensing herpes: more than Toll. Rev. Med. Virol. 22(2):106 -121.
36. Montgomery RI, Warner MS, Lum BJ, Spear PG. 1996. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87:427- 436.
37. Nordén R, Nystrom K, Olofsson S. 2009. Activation of host antiviral RNA-sensing factors necessary for herpes simplex virus type 1-activated transcription of host cell fucosyltransferase genes FUT3, FUT5, and FUT6 and subsequent expression of sLe(x) in virus-infected cells. Glycobiology 19:776 -788.
38. Paladino P, Cummings DT, Noyce RS, Mossman KL. 2006. The IFNindependent response to virus particle entry provides a first line of antiviral defense that is independent of TLRs and retinoic acid-inducible gene I. J. Immunol. 177:8008-8016.
39. Paladino P, Mossman KL. 2009. Mechanisms employed by herpes simplex virus 1 to inhibit the interferon response. J. Interferon Cytokine Res. 29:599-607.
40. Paludan SR, Bowie AG, Horan KA, Fitzgerald KA. 2011. Recognition of herpesviruses by the innate immune system. Nat. Rev. Immunol. 11:143-154.
41. Patel A, et al. 1998. Herpes simplex type 1 induction of persistent NFkappa B nuclear translocation increases the efficiency of virus replication. Virology 247:212-222.
42. Rasmussen SB, et al. 2009. Herpes simplex virus infection is sensed by both Toll-like receptors and retinoic acid-inducible gene-like receptors, which synergize to induce type I interferon production. J. Gen. Virol. 90:74 -78.
43. Reske A, Pollara G, Krummenacher C, Katz DR, Chain BM. 2008. Glycoprotein-dependent and TLR2-independent innate immune recognition of herpes simplex virus-1 by dendritic cells. J. Immunol. 180:7525-7536.
44. Roberts KL, Baines JD. 2011. UL31 of herpes simplex virus 1 is necessary for optimal NF-kappaB activation and expression of viral gene products. J. Virol. 85:4947- 4953.
45. Roizman B, Knipe DM, Whitley RJ. 2007. Herpes simplex viruses, p 2501-2601. In Knipe DM, et al. (ed), Fields virology, 5th ed, vol 2. Lippincott Williams & Wilkins, New York, NY.
46. Santoro MG, Rossi A, Amici C. 2003. NF-kappaB and virus infection: who controls whom. EMBO J. 22:2552-2560.
47. Satoh T, et al. 2008. PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B. Cell 132:935-944.
48. Sciortino MT, et al. 2008. Involvement of gD/HVEM interaction in NFkB-dependent inhibition of apoptosis by HSV-1 gD. Biochem. Pharmacol. 76:1522-1532.
49. Sciortino MT, et al. 2008. Involvement of HVEM receptor in activation of nuclear factor kappaB by herpes simplex virus 1 glycoprotein D. Cell Microbiol. 10:2297-2311.
50. Showalter SD, Zweig M, Hampar B. 1981. Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4. Infect. Immun. 34:684-692.
51. Shukla D, Spear PG. 2001. Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J. Clin. Invest. 108:503-510.
52. Suenaga T, et al. 2010. Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses. Proc. Natl. Acad. Sci. U. S. A. 107:866-871.
53. Sun SC. 2011. Non-canonical NF-kappaB signaling pathway. Cell Res. 21:71- 85.
54. Taddeo B, Luo TR, Zhang W, Roizman B. 2003. Activation of NFkappaB in cells productively infected with HSV-1 depends on activated protein kinase R and plays no apparent role in blocking apoptosis. Proc. Natl. Acad. Sci. U. S. A. 100:12408 -12413.
55. Taddeo B, Zhang W, Lakeman F, Roizman B. 2004. Cells lacking NFkappaB or in which NF-kappaB is not activated vary with respect to ability to sustain herpes simplex virus 1 replication and are not susceptible to apoptosis induced by a replication-incompetent mutant virus. J. Virol. 78:11615-11621.
56. Vabulas RM, et al. 2001. Endocytosed HSP60s use Toll-like receptor 2 (TLR2) and TLR4 to activate the Toll/interleukin-1 receptor signaling pathway in innate immune cells. J. Biol. Chem. 276:31332-31339.
57. van Lint AL, et al. 2010. Herpes simplex virus immediate-early ICP0 protein inhibits Toll-like receptor 2-dependent inflammatory responses and NF-kappaB signaling. J. Virol. 84:10802-10811.
58. WuDunn D, Spear PG. 1989. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63:52-58.
59. Yao XD, Rosenthal KL. 2011. Herpes simplex virus type 2 virion host shutoff protein suppresses innate dsRNA antiviral pathways in human vaginal epithelial cells. J. Gen. Virol. 92:1981-1993.
60. Yurochko AD, et al. 1997. The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection. J. Virol. 71:5051-5059.
61. Zhang SY, et al. 2007. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317:1522-1527.